As Chemocentryx (CCXI) Stock Rose, Holder Bvf Has Cut by $5.02 Million Its Stake; Mfs Invt Grade Mun Tr Sh Ben Int (CXH) Market Value Declined While Karpus Management Lifted Stake by $704,565




August 7, 2018 – By Ronnie Lemelle

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Bvf Inc decreased its stake in Chemocentryx Inc (CCXI) by 5.09% based on its latest 2018Q1 regulatory filing with the SEC. Bvf Inc sold 386,100 shares as the company’s stock rose 32.26% while stock markets declined. The hedge fund held 7.20 million shares of the health care company at the end of 2018Q1, valued at $97.94 million, down from 7.59M at the end of the previous reported quarter. Bvf Inc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $537.70 million market cap company. It closed at $10.94 lastly. It is down 83.50% since August 7, 2017 and is uptrending. It has outperformed by 70.93% the S&P500. Some Historical CCXI News: 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018; 09/05/2018 – ChemoCentryx 1Q Loss/Shr 19c; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

Karpus Management Inc increased its stake in Mfs Invt Grade Mun Tr Sh Ben Int (CXH) by 5% based on its latest 2018Q1 regulatory filing with the SEC. Karpus Management Inc bought 78,285 shares as the company’s stock declined 1.29% with the market. The institutional investor held 1.64M shares of the company at the end of 2018Q1, valued at $15.44M, up from 1.57M at the end of the previous reported quarter. Karpus Management Inc who had been investing in Mfs Invt Grade Mun Tr Sh Ben Int for a number of months, seems to be bullish on the $84.36M market cap company. It closed at $9.26 lastly. It is down 9.00% since August 7, 2017 and is downtrending. It has underperformed by 21.57% the S&P500.

Analysts await ChemoCentryx, Inc. (NASDAQ:CCXI) to report earnings on August, 9 after the close. They expect $-0.11 EPS, up 42.11% or $0.08 from last year’s $-0.19 per share. After $-0.19 actual EPS reported by ChemoCentryx, Inc. for the previous quarter, Wall Street now forecasts -42.11% EPS growth.

Another recent and important ChemoCentryx, Inc. (NASDAQ:CCXI) news was published by Nasdaq.com which published an article titled: “ChemoCentryx to Hold Second Quarter 2018 Financial Results Conference Call on Thursday, August 9, 2018” on August 02, 2018.

Investors sentiment decreased to 1 in Q1 2018. Its down 0.30, from 1.3 in 2017Q4. It turned negative, as 10 investors sold CCXI shares while 36 reduced holdings. 24 funds opened positions while 22 raised stakes. 24.22 million shares or 3.03% more from 23.51 million shares in 2017Q4 were reported. Public Employees Retirement Systems Of Ohio reported 117,524 shares stake. Smith Asset Mgmt Gru LP holds 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 26,447 shares. Metropolitan Life Ins has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 8,715 shares. Millennium Lc holds 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 324,112 shares. Ameritas Prns reported 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Baker Bros Advsr Limited Partnership invested in 0.05% or 414,029 shares. Century has 31,279 shares. California-based Farallon Mngmt Ltd Liability Company has invested 0.09% in ChemoCentryx, Inc. (NASDAQ:CCXI). New York State Common Retirement Fund holds 37,100 shares. American Grp Inc owns 15,795 shares. Arrowstreet Ltd Partnership reported 34,216 shares. Manufacturers Life Ins The reported 20,352 shares. Bridgeway Cap Management has 50,246 shares for 0.01% of their portfolio. Sei Invests has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Strs Ohio owns 55,500 shares.

Among 7 analysts covering ChemoCentryx (NASDAQ:CCXI), 5 have Buy rating, 1 Sell and 1 Hold. Therefore 71% are positive. ChemoCentryx had 9 analyst reports since September 3, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Tuesday, August 8 by Cowen & Co. JMP Securities initiated the shares of CCXI in report on Tuesday, February 21 with “Mkt Outperform” rating. The firm has “Sell” rating given on Thursday, September 3 by Zacks. Zacks downgraded ChemoCentryx, Inc. (NASDAQ:CCXI) on Monday, September 21 to “Sell” rating. JP Morgan maintained ChemoCentryx, Inc. (NASDAQ:CCXI) rating on Tuesday, March 13. JP Morgan has “Overweight” rating and $16 target. The stock has “Buy” rating by JMP Securities on Thursday, August 10.

Bvf Inc, which manages about $999.89 million and $986.48 million US Long portfolio, upped its stake in Verastem Inc (NASDAQ:VSTM) by 487,000 shares to 2.74M shares, valued at $8.16 million in 2018Q1, according to the filing. It also increased its holding in Pieris Pharmaceuticals Inc by 968,987 shares in the quarter, for a total of 3.59 million shares, and has risen its stake in Protagonist Therapeutics Inc.

Since May 1, 2018, it had 0 insider buys, and 12 insider sales for $7.89 million activity. 100 ChemoCentryx, Inc. (NASDAQ:CCXI) shares with value of $1,410 were sold by KANAYA SUSAN M. Cappel Markus J. had sold 50,000 shares worth $550,912 on Tuesday, May 1.

Investors sentiment decreased to 1.13 in Q1 2018. Its down 0.54, from 1.67 in 2017Q4. It dropped, as 2 investors sold CXH shares while 6 reduced holdings. 6 funds opened positions while 3 raised stakes. 2.74 million shares or 1.42% more from 2.71 million shares in 2017Q4 were reported. Moreover, Dynamic Advisor Solutions Limited Liability Com has 0.03% invested in MFS Investment Grade Municipal (NYSE:CXH). Ameriprise Financial Incorporated invested in 16,934 shares. Yakira Cap Management owns 10,779 shares or 0.02% of their US portfolio. Pnc Fincl Serv Grp Inc Inc holds 59,920 shares. 9,000 were reported by Fifth Third Bancshares. Live Your Vision Ltd Co holds 1,000 shares or 0% of its portfolio. Karpus Incorporated reported 0.69% in MFS Investment Grade Municipal (NYSE:CXH). Lpl Fincl Ltd Com accumulated 0% or 28,604 shares. Royal Fincl Bank Of Canada holds 5,325 shares. Wells Fargo & Mn reported 12,903 shares. Asset Mngmt has invested 0.07% of its portfolio in MFS Investment Grade Municipal (NYSE:CXH). Koshinski Asset Mngmt accumulated 57,520 shares. Moreover, Webster Bancorp N A has 0.01% invested in MFS Investment Grade Municipal (NYSE:CXH). Comml Bank Of America De stated it has 0% of its portfolio in MFS Investment Grade Municipal (NYSE:CXH). Janney Montgomery Scott Limited Liability Com accumulated 22,454 shares.

Karpus Management Inc, which manages about $2.60B and $2.23B US Long portfolio, decreased its stake in Mfs Inter Income Tr Sh Ben Int (NYSE:MIN) by 347,934 shares to 1.75M shares, valued at $6.88M in 2018Q1, according to the filing. It also reduced its holding in Vanguard Index Fds S&P 500 Etf Sh (VOO) by 12,009 shares in the quarter, leaving it with 1.03 million shares, and cut its stake in Western Asset Clym Infl Opp In (WIW).

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.




Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *